Advancing the global public health agenda for NAFLD: a consensus statement
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …
approximately one-quarter of the global adult population, causing a substantial burden of ill …
[HTML][HTML] The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
Background & Aims Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent, yet
largely underappreciated liver condition which is closely associated with obesity and …
largely underappreciated liver condition which is closely associated with obesity and …
Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment
LJM Heyens, D Busschots, GH Koek, G Robaeys… - Frontiers in …, 2021 - frontiersin.org
An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver
disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis …
disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis …
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of 25% and is a leading
cause of cirrhosis and hepatocellular carcinoma. NAFLD encompasses a disease …
cause of cirrhosis and hepatocellular carcinoma. NAFLD encompasses a disease …
[HTML][HTML] The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes
Z Younossi, P Aggarwal, I Shrestha, J Fernandes… - JHEP Reports, 2022 - Elsevier
Background & Aims Non-alcoholic steatohepatitis (NASH) is associated with increased
mortality and a high clinical burden. NASH adversely impacts patients' health-related quality …
mortality and a high clinical burden. NASH adversely impacts patients' health-related quality …
Steatotic liver disease: pathophysiology and emerging pharmacotherapies
M Kokkorakis, E Muzurović, Š Volčanšek… - Pharmacological …, 2024 - ASPET
Steatotic liver disease (SLD) displays a dynamic and complex disease phenotype.
Consequently, the metabolic dysfunction-associated steatotic liver disease …
Consequently, the metabolic dysfunction-associated steatotic liver disease …
Dietary interventions in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis
V Houttu, S Csader, M Nieuwdorp… - Frontiers in …, 2021 - frontiersin.org
Background: With no approved pharmacotherapy to date, the present therapeutic
cornerstone for non-alcoholic fatty liver diseases (NAFLD) is a lifestyle intervention …
cornerstone for non-alcoholic fatty liver diseases (NAFLD) is a lifestyle intervention …
[HTML][HTML] Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review
LL Grønkjær, MM Lauridsen - JHEP Reports, 2021 - Elsevier
Background & Aims In an attempt to uncover unmet patient needs, this review aims to
synthesise quantitative and qualitative studies on patients' quality of life and their experience …
synthesise quantitative and qualitative studies on patients' quality of life and their experience …
Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitis
EK Wirth, T Puengel, J Spranger… - Expert Review of …, 2022 - Taylor & Francis
Introduction Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic
liver disease worldwide and closely interconnected to the metabolic syndrome. Liver …
liver disease worldwide and closely interconnected to the metabolic syndrome. Liver …
Development of a patient-reported outcome measure for non-alcoholic steatohepatitis (NASH-CHECK): results of a qualitative study
LC Doward, MM Balp, J Twiss, C Slota, D Cryer… - The Patient-Patient …, 2021 - Springer
Background Non-alcoholic steatohepatitis (NASH) is a progressive form of non-alcoholic
fatty liver disease characterized by excessive liver fat accumulation, inflammation, cell injury …
fatty liver disease characterized by excessive liver fat accumulation, inflammation, cell injury …